MOSCOW (Reuters) - The head of Russia’s RDIF sovereign wealth fund, Kirill Dmitriev, said on Tuesday the Sputnik V coronavirus vaccine would be approved for domestic use by 25 countries within the next few weeks.
“Our Sputnik V vaccine is now registered in 14 countries. We’ll have more than 25 registrations within the next couple of weeks,” Dmitriev told a virtual meeting of the World Economic Forum.
Reporting by Polina Ivanova; Writing by Maria Kiselyova; Editing by Andrew Heavens
Our Standards: The Thomson Reuters Trust Principles.